Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
NCT06868758
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
HER2 Positive Breast Carcinoma
Neoadjuvant Therapy
Sponsor
Chongqing General Hospital